305 related articles for article (PubMed ID: 29171476)
1. [Recombinant human parathyroid hormone in the therapy of hypoparathyroidism].
Eremkina AK; Mokrysheva NG; Kovaleva EV; Krupinova YA
Ter Arkh; 2017; 89(10):80-86. PubMed ID: 29171476
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone therapy for hypoparathyroidism.
Cusano NE; Rubin MR; Bilezikian JP
Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):47-55. PubMed ID: 25617172
[TBL] [Abstract][Full Text] [Related]
3. Management of Hypoparathyroidism: Present and Future.
Bilezikian JP; Brandi ML; Cusano NE; Mannstadt M; Rejnmark L; Rizzoli R; Rubin MR; Winer KK; Liberman UA; Potts JT
J Clin Endocrinol Metab; 2016 Jun; 101(6):2313-24. PubMed ID: 26938200
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
[TBL] [Abstract][Full Text] [Related]
5. Hypoparathyroidism - disease update and emerging treatments.
Monis EL; Mannstadt M
Ann Endocrinol (Paris); 2015 May; 76(2):84-8. PubMed ID: 25882889
[TBL] [Abstract][Full Text] [Related]
6. Mini-review: new therapeutic options in hypoparathyroidism.
Cusano NE; Rubin MR; Sliney J; Bilezikian JP
Endocrine; 2012 Jun; 41(3):410-4. PubMed ID: 22311174
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism.
Kim ES; Keating GM
Drugs; 2015 Jul; 75(11):1293-303. PubMed ID: 26177893
[TBL] [Abstract][Full Text] [Related]
8. Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism.
Marcucci G; Della Pepa G; Brandi ML
Expert Opin Drug Saf; 2017 May; 16(5):617-625. PubMed ID: 28332412
[TBL] [Abstract][Full Text] [Related]
9. Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study.
Clarke BL; Vokes TJ; Bilezikian JP; Shoback DM; Lagast H; Mannstadt M
Endocrine; 2017 Jan; 55(1):273-282. PubMed ID: 27734257
[TBL] [Abstract][Full Text] [Related]
10. Hypocalcemic disorders.
Bove-Fenderson E; Mannstadt M
Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):639-656. PubMed ID: 30449546
[TBL] [Abstract][Full Text] [Related]
11. Therapy of hypoparathyroidism with intact parathyroid hormone.
Rubin MR; Sliney J; McMahon DJ; Silverberg SJ; Bilezikian JP
Osteoporos Int; 2010 Nov; 21(11):1927-34. PubMed ID: 20094706
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis and management of hypoparathyroidism and other hypocalcemic disorders.
Schneider AB; Sherwood LM
Metabolism; 1975 Jul; 24(7):871-98. PubMed ID: 166271
[TBL] [Abstract][Full Text] [Related]
13. Impact of recombinant PTH on management of hypoparathyroidism: a systematic review.
Ramakrishnan Y; Cocks HC
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):827-35. PubMed ID: 25567344
[TBL] [Abstract][Full Text] [Related]
14. PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment.
Sikjaer T; Amstrup AK; Rolighed L; Kjaer SG; Mosekilde L; Rejnmark L
J Bone Miner Res; 2013 Oct; 28(10):2232-43. PubMed ID: 23649554
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial.
Khan AA; Rubin MR; Schwarz P; Vokes T; Shoback DM; Gagnon C; Palermo A; Marcocci C; Clarke BL; Abbott LG; Hofbauer LC; Kohlmeier L; Pihl S; An X; Eng WF; Smith AR; Ukena J; Sibley CT; Shu AD; Rejnmark L
J Bone Miner Res; 2023 Jan; 38(1):14-25. PubMed ID: 36271471
[TBL] [Abstract][Full Text] [Related]
16. Hypoparathyroidism: is it that easy to treat?
Triantafyllou E; Yavropoulou MP; Anastasilakis AD; Makras P
Hormones (Athens); 2019 Mar; 18(1):55-63. PubMed ID: 29876797
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism.
Mannstadt M; Clarke BL; Bilezikian JP; Bone H; Denham D; Levine MA; Peacock M; Rothman J; Shoback DM; Warren ML; Watts NB; Lee HM; Sherry N; Vokes TJ
J Clin Endocrinol Metab; 2019 Nov; 104(11):5136-5147. PubMed ID: 31369089
[TBL] [Abstract][Full Text] [Related]
18. Hypoparathyroidism.
Bilezikian JP
J Clin Endocrinol Metab; 2020 Jun; 105(6):1722-36. PubMed ID: 32322899
[TBL] [Abstract][Full Text] [Related]
19. Use of parathyroid hormone in hypoparathyroidism.
Cusano NE; Rubin MR; Irani D; Sliney J; Bilezikian JP
J Endocrinol Invest; 2013 Dec; 36(11):1121-7. PubMed ID: 24445125
[TBL] [Abstract][Full Text] [Related]
20. Hypoparathyroidism.
Mannstadt M; Bilezikian JP; Thakker RV; Hannan FM; Clarke BL; Rejnmark L; Mitchell DM; Vokes TJ; Winer KK; Shoback DM
Nat Rev Dis Primers; 2017 Aug; 3():17055. PubMed ID: 28857066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]